Search
Mizoribine
go.drugbank.com/drugs/DB12617InvestigationalMizoribine has been investigated for the treatment of Rheumatoid Arthritis.
Patidegib
go.drugbank.com/drugs/DB12655InvestigationalPatidegib has been investigated for the treatment of Conventional Chondrosarcoma.
Serlopitant
go.drugbank.com/drugs/DB12973InvestigationalSerlopitant has been investigated for the treatment of Prurigo Nodularis.
Phenserine
go.drugbank.com/drugs/DB04892InvestigationalAxonyx announced on 20 September 2005 that phenserine was ineffective in two curtailed phase 3 trials. … Unlike currently marketed AChE inhibitors, it has a dual mechanism of action that also includes anti-amyloid activity, which may confer disease-modifying effects in patients with AD.
Unexpanded umbilical cord-derived allogeneic CD34- hematopoietic stem cells
go.drugbank.com/drugs/DB28348Approved[L54146] Zemcelpro was granted conditional marketing authorization in the European Union in August 2025 for use in allogeneic hematopoietic stem cell transplantation following myeloablative conditioning
Sugammadex
go.drugbank.com/drugs/DB06206ApprovedInvestigationalSugammadex (brand name Bridion) is marketed by Merck Sharp and Dohme, and was approved by the United States FDA on December 15, 2015.
SP-8203
go.drugbank.com/drugs/DB11670InvestigationalSP-8203 has been used in trials studying the treatment of Ischemic Stroke.
Olaptesed Pegol
go.drugbank.com/drugs/DB11707InvestigationalOlaptesed Pegol has been investigated for the treatment of Hematopoietic Stem Cell Transplantation.
Angiotensin 1-7
go.drugbank.com/drugs/DB11720InvestigationalTXA127 has been investigated for the treatment of Miscellaneous Peripheral Blood Cell Abnormalities.
Latrepirdine
go.drugbank.com/drugs/DB11725InvestigationalLatrepirdine has been investigated for the treatment of Alzheimer's Disease and Huntington's Disease.